Aaron Martin
President, Medicare AdvantageHumana
PresidentView Profile →President, Advanced Surgery & Commercial Excellence · Baxter International
Steve Wallace is president of Advanced Surgery and Commercial Excellence at Baxter. He previously led Stryker’s Knee Arthroplasty business and held an international presidency at Wright Medical.
Last reviewed: Nov 2, 2026
President, Advanced Surgery & Commercial Excellence
Baxter International
Last Reviewed: November 2, 2026
Steve Wallace is president of Advanced Surgery and Commercial Excellence at Baxter. He previously led Stryker’s Knee Arthroplasty business and held an international presidency at Wright Medical.
Wallace joined Baxter in 2022 after more than two decades in the medical-device industry. Immediately before Baxter, he was general manager of Stryker’s Knee Arthroplasty business. His earlier experience included serving as an international president at Wright Medical.
As president of Baxter’s Advanced Surgery business, Wallace represented the company during the 2023 U.S. regulatory milestone for PerClot, an absorbable hemostatic system. Artivion announced FDA premarket approval in May 2023 and the planned transfer of that approval to Baxter, which had acquired the product line in 2021. Wallace acknowledged Artivion’s work through the review process and explained how the product would broaden Baxter’s portfolio of solutions for intraoperative bleeding.
The arrangement included transitional manufacturing and supply by Artivion before transfer of manufacturing operations. Wallace’s current role combines Advanced Surgery leadership with Commercial Excellence, following earlier operating assignments in orthopedic devices and international medical-technology markets.
Wallace earned a bachelor’s degree in business administration from the University of Wisconsin–Madison and an MBA from the University of Florida’s Hough Graduate School of Business.